Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1998-03-10
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 12, 424 852, A61K 4505
Patent
active
057261482
ABSTRACT:
A method of treating metabolic bone diseases comprising using a pharmaceutical composition which comprises as an active ingredient IL-1 receptor, a soluble fragment consisting of an extracellular domain of IL-1R or a fragment thereof derived from mammals. The composition has a bone resorption inhibiting activity and is useful for the therapy and prophylaxis of metabolic bone diseases.
REFERENCES:
patent: 5180812 (1993-01-01), Dower et al.
patent: 5319071 (1994-06-01), Dower et al.
M. Tanihara et al., "A Synthetic Peptide Corresponding to 86-93 of the Type I IL-1 Receptor Binds Human Recombinant IL-1 (.alpha. and .beta.) and Inhibits IL-1 Actions in Vitro and in Vivo", Biochem. Biophys. Res. Comm., vol. 188, No. 2, Oct. 30, 1992, pp. 912-920.
S.K. Dower et al., "Retention of Ligand Binding Activity By the Extracellular Domain of the IL-1 Receptor", J. Immunology, vol. 142, No. 12 Jun. 15, 1989, pp. 4314-4320.
C.R. Maliszewski et al., "Cytokine Receptors and B Cell Functions: I. Recombinant Soluble Receptors Specifically Inhibit IL-1-and IL-4-Induced B Cell Activities in Vitro," Journal of Immunology, vol. 144, No. 8, Apr. 15, 1990, pp. 3028-3033.
P. Seckinger et al., "Natural and Recombinant Human IL-1 Receptor Antagonists Block the Effects of IL-1 on Bone Resorption and Prostaglandin Production", Journal of Immunology, vol. 145, No. 12, Dec. 15, 1990, pp. 4181-4184.
M. Gowen et al., Nature, vol. 306 (1983) pp. 378-381.
J. Pfeilschifter et al., J. of Bone and Mineral Res., vol. 4, No. 1 (1989) pp. 113-118.
B.M. Thomson et al., J. Exp. Med. (1986) pp. 104-112.
Gershenwald et al PNAS 87, 1990, pp. 966-970.
Fanslow et al Science 248, 1990, pp. 739-742.
Cominelli et al J. Clin. Invest 86, 1990, pp. 972-980.
Katoh Masakazu
Kitamura Kazuyuki
Draper Garnette D.
Hoechst Japan Limited
LandOfFree
Method of treating metabolic bone diseases with an IL-1 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating metabolic bone diseases with an IL-1 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating metabolic bone diseases with an IL-1 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139340